Incyte (INCY) Stock Forecast & Price Target
INCY Analyst Ratings
Moderate Buy
11Buy11Hold0Sell
Based on 22 analysts giving stock ratings to Incyte in the past 3 months
INCY Stock 12 Month Forecast
Average Price Target
MXN 2,525.65▲(27.02% Upside)Based on 22 Wall Street analysts offering 12 month price targets for Incyte in the last 3 months. The average price target is MXN 2,525.65 with a high forecast of MXN 2,950.35 and a low forecast of MXN 1,954.37. The average price target represents a 27.02% change from the last price of MXN 1,988.32.
Past 12 Months12 Month ForecastJan2026Oct2026
HighMXN 2.95K
AverageMXN 2.53K
LowMXN 1.95K
Highest Price TargetHighestMXN 2,950.35Average Price TargetMXN 2,525.65Lowest Price TargetLowestMXN 1,954.37
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| John Newman | Canaccord Genuity | MXN 2,856.39 | buy | 43.66%Upside | Reiterated | 10/30/26 | ||
| Mitchell Kapoor | H.C. Wainwright | MXN 2,856.39 | buy | 43.66%Upside | Reiterated | 10/30/26 | ||
| Etzer Darout | Barclays | MXN 2,612.09→MXN 2,687.26 | buy | 35.15%Upside | Reiterated | 10/30/26 | ||
| Ashwani Verma | UBS | MXN 2,386.59 | hold | 20.03%Upside | Reiterated | 10/30/26 | ||
 Chris YuNot Ranked | Morgan Stanley | MXN 2,236.25→MXN 2,179.88 | hold | 9.63%Upside | Assigned | 10/30/26 | ||
| Gavin Clark-Gartner | Evercore ISI | MXN 2,349.01→MXN 2,386.59 | hold | 20.03%Upside | Reiterated | 10/30/26 | ||
| Stephen Willey | Stifel Nicolaus | MXN 2,950.35 | buy | 48.38%Upside | Reiterated | 10/30/26 | ||
| Michael Schmidt | Guggenheim | MXN 2,856.39 | buy | 43.66%Upside | Reiterated | 10/29/26 | ||
| Brian Abrahams | RBC Capital | MXN 2,142.29→MXN 2,198.67 | hold | 10.58%Upside | Assigned | 10/29/26 | ||
| Jay Olson | Oppenheimer | MXN 2,255.05→MXN 2,706.05 | buy | 36.10%Upside | Upgraded | 10/29/26 | ||
| Derek Archila | Wells Fargo | MXN 2,405.38→MXN 2,386.59 | hold | 20.03%Upside | Reiterated | 10/29/26 | ||
| Unknown AnalystNot Ranked | Cantor Fitzgerald | ― | hold | ― | Reiterated | 10/29/26 | ||
| Srikripa Devarakonda | Truist Financial | MXN 2,161.09 | hold | 8.69%Upside | Reiterated | 10/27/26 | ||
| Tazeen Ahmad | Bank of America Securities | MXN 2,630.89 | buy | 32.32%Upside | Reiterated | 10/26/26 | ||
| Evan Seigerman | BMO Capital | MXN 2,442.97 | hold | 22.87%Upside | Reiterated | 10/26/26 |
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| John Newman | 10/30/26 | MXN 2,856.39 | buy | 43.66%Upside | Reiterated | Canaccord Genuity | ||
| Mitchell Kapoor | 10/30/26 | MXN 2,856.39 | buy | 43.66%Upside | Reiterated | H.C. Wainwright | ||
| Etzer Darout | 10/30/26 | MXN 2,612.09→MXN 2,687.26 | buy | 35.15%Upside | Reiterated | Barclays | ||
| Ashwani Verma | 10/30/26 | MXN 2,386.59 | hold | 20.03%Upside | Reiterated | UBS | ||
| Chris YuNot Ranked | 10/30/26 | MXN 2,236.25→MXN 2,179.88 | hold | 9.63%Upside | Assigned | Morgan Stanley | ||
| Gavin Clark-Gartner | 10/30/26 | MXN 2,349.01→MXN 2,386.59 | hold | 20.03%Upside | Reiterated | Evercore ISI | ||
| Stephen Willey | 10/30/26 | MXN 2,950.35 | buy | 48.38%Upside | Reiterated | Stifel Nicolaus | ||
| Michael Schmidt | 10/29/26 | MXN 2,856.39 | buy | 43.66%Upside | Reiterated | Guggenheim | ||
| Brian Abrahams | 10/29/26 | MXN 2,142.29→MXN 2,198.67 | hold | 10.58%Upside | Assigned | RBC Capital | ||
| Jay Olson | 10/29/26 | MXN 2,255.05→MXN 2,706.05 | buy | 36.10%Upside | Upgraded | Oppenheimer | ||
| Derek Archila | 10/29/26 | MXN 2,405.38→MXN 2,386.59 | hold | 20.03%Upside | Reiterated | Wells Fargo | ||
| Unknown AnalystNot Ranked | 10/29/26 | ― | hold | ― | Reiterated | Cantor Fitzgerald | ||
| Srikripa Devarakonda | 10/27/26 | MXN 2,161.09 | hold | 8.69%Upside | Reiterated | Truist Financial | ||
| Tazeen Ahmad | 10/26/26 | MXN 2,630.89 | buy | 32.32%Upside | Reiterated | Bank of America Securities | ||
| Evan Seigerman | 10/26/26 | MXN 2,442.97 | hold | 22.87%Upside | Reiterated | BMO Capital |
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Best Analysts Covering Incyte
3 Months
Success Rate10/11 ratings generated profit
91%
Average Return
+14.64%
Copying Stephen Willey's trades and holding each position for 3 Months would result in 90.91% of your transactions generating a profit, with an average return of +14.64% per trade.
1 Year
Success Rate19/19 ratings generated profit
100%
Average Return
+33.03%
Copying Tazeen Ahmad's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +33.03% per trade.
2 Years
Success Rate19/19 ratings generated profit
100%
Average Return
+45.53%
Copying Tazeen Ahmad's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +45.53% per trade.
INCY Analyst Recommendation Trends
| Rating | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 40 | 40 | 21 | 30 | 23 |
| Hold | 41 | 41 | 29 | 26 | 21 |
| Sell | 3 | 2 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 84 | 83 | 50 | 56 | 44 |
In the current month, INCY has received 23 Buy Ratings, 21 Hold Ratings, and 0 Sell Ratings. INCY average Analyst price target in the past 3 months is 2,525.65.
INCY Financial Forecast
HighMXN 57.88
ConsensusMXN 36.02
LowMXN 27.64
INCY Earnings Forecast
Next quarter’s earnings estimate for INCY is MXN 36.02 with a range of MXN 27.64 to MXN 57.88. The previous quarter’s EPS was -MXN 67.65. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
HighMXN 30.2B
ConsensusMXN 29B
LowMXN 26.4B
INCY Sales Forecast
Next quarter’s sales forecast for INCY is MXN 29.00B with a range of MXN 26.44B to MXN 30.19B. The previous quarter’s sales results were MXN 29.26B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
INCY Stock Forecast FAQ
What is MX:INCY’s average 12-month price target, according to analysts?
Based on analyst ratings, Incyte’s 12-month average price target is Mex$2,525.65.
What is MX:INCY’s upside potential, based on the analysts’ average price target?
Incyte has 27.02% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Incyte a Buy, Sell or Hold?
Incyte has a consensus rating of Moderate Buy, which is based on 11 buy ratings, 11 hold ratings and 0 sell ratings.
What is Incyte’s share price target?
The average share price target for Incyte is Mex$2,525.65. This is based on 22 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is Mex$2,950.35, and the lowest forecast is Mex$1,954.37. The average share price target represents a 27.02% increase from the current price of Mex$1,988.32.
What do analysts say about Incyte?
Incyte’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 22 Wall Street analysts.
How can I buy shares of Incyte?
To buy shares of MX:INCY, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
